Welcome to our dedicated page for AXT SEC filings (Ticker: AXTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AXT, Inc. filings document the regulatory disclosures of a Nasdaq-listed manufacturer of compound semiconductor substrate wafers. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD information, exhibit filings for earnings releases, and capital-structure disclosures involving its common stock.
The filing record also includes material definitive agreement disclosure for an underwriting agreement, exchange-registration information for AXTI common stock, and definitive proxy materials addressing shareholder voting matters, board and committee governance, director independence, and executive compensation.
AXT, Inc. furnished an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference as stated.
The company notes the information in Exhibit 99.1 is being “furnished” under General Instruction B.2 and is not deemed “filed” for purposes of Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act. It will not be incorporated by reference into other filings unless expressly stated.
AXT Inc. (AXTI) disclosed that its CEO acquired 100,000 shares of common stock on 10/28/2025 through a restricted stock grant. The award was made under the company’s 2025 Equity Incentive Plan, is exempt under Rule 16b-3, and was granted in consideration for past services, subject to a restricted stock agreement.
Following the transaction, the CEO beneficially owned 2,549,490 shares, held directly.
AXT, Inc. reported an insider equity grant. The CFO received 37,500 shares of restricted stock on October 28, 2025, reported with transaction code “A.” The award was granted under the company’s 2025 Equity Incentive Plan and is described as consideration for past services rendered, exempt under Rule 16b-3 and subject to a restricted stock agreement.
Following this grant, the reporting person beneficially owned 566,204 shares, held directly. This filing reflects a non-cash equity compensation event and does not involve an open-market purchase or sale.
AXT Inc (AXTI) reported an insider transaction by its CFO. On 10/20/2025, the officer exercised stock options for 10,280 shares at $2.18 per share (transaction code M), adding the shares to direct holdings.
After the transaction, the officer directly beneficially owned 528,704 common shares. Derivative securities beneficially owned following the event were 247,828 stock options originally granted on 11/02/2015 and expiring on 11/02/2025.
AXT, Inc. disclosed that its subsidiary Beijing Tongmei Xtal Technology has received export permits from the Ministry of Commerce of the PRC to resume shipping indium phosphide (InP) substrates to certain additional customers. The company expects this permitting to generate several million dollars of revenue that was not included in its Q3 2025 forecast announced July 31, 2025. The export permits relate to controls imposed after the Feb. 4, 2025 PRC announcement restricting exports of materials including indium. Customer shipments remain subject to normal operational and regulatory uncertainties, and the company qualified these forward-looking statements under its Safe Harbor language.
AXT Inc (AXTI) director Leonard J. LeBlanc received a prorated equity grant of 29,112 shares of common stock on 07/29/2025. The grant was calculated using the closing share price of $2.29 on that date and vests on May 15, 2026, subject to continuous service through the vesting date. After the grant, the filing reports Mr. LeBlanc beneficially owns 122,512 shares. The transaction was reported on a Form 4 signed by an attorney-in-fact on 08/14/2025. The grant aligns the director’s compensation with shareholder value through a time-based vesting schedule.
AXT, Inc. reported a significant decline in revenue and widening losses in the quarter ended June 30, 2025. Quarterly revenue fell to $17.97 million from $27.92 million a year earlier, and six-month revenue declined to $37.33 million from $50.61 million. Gross profit contracted sharply to $1.43 million for the quarter and to $0.19 million for the six months, compared with $7.65 million and $13.75 million a year ago, respectively. Net loss attributable to AXT, Inc. was $7.01 million for the quarter and $15.81 million for six months, driving basic EPS of $(0.16) and $(0.36) for the quarter and six months.
On the balance sheet, cash and cash equivalents were $27.01 million with restricted cash of $8.10 million, totaling $35.11 million; short-term loans increased to $55.93 million. Inventories were $80.06 million and total assets were $329.00 million. The company holds $14.3 million of strategic investments in privately held raw material companies and recognized a $145,000 impairment on a fair-value investment in Jia Mei during the period. A putative securities class action is pending and a derivative suit dismissal was affirmed with an appeal filed.
On 29 Jul 2025, AXT, Inc. (AXTI) filed an 8-K announcing two board changes under Item 5.02. Leonard J. LeBlanc, a former director (2003-2021) and prior audit-committee chair, was re-appointed as a Class III director, filling the vacancy created by the recent passing of Ms. Christine Russell. His term runs through 29 Jul 2027. Because LeBlanc earned >$120 k in 2022 under a now-terminated consulting agreement, he is not yet independent per Nasdaq rules; however, the board used the “exceptional and limited circumstances” exemption to place him on the Audit, Compensation and Nominating & Governance Committees. Independence will be re-evaluated on or after 1 Jan 2026, when the look-back period lapses.
LeBlanc will receive standard non-employee director pay plus an initial grant of 29,112 restricted shares that vest 15 May 2026. No other related-party transactions or family ties were disclosed.
The board also named independent director Jesse Chen as Audit Committee Chair, effective immediately, with an additional $20 k annual cash retainer. No financial statements were included in this filing.